Table 2. p Values estimated for neutralization assays evaluated for both immunization schedules.

Figure	Parameter evaluated	Schedule;preimmune value	Preimmune compared to
			2 Weeks after second dose	4 Weeks after second dose
Figure 1A	sVNT (IU/mL; p value)	0–14 days; 16.4	50.9; <0.0001	51.2; <0.0001
		0–28 days; 17.7	178.2; <0.0001	131.7; <0.0001
Figure 1B	cVNT (Ancestral) (GMT; p value)	0–14 days; 2.04	46.9; <0.0001	33.8; <0.0001
		0–28 days; 2.08	90.2; <0.0001	61.1; <0.0001
Figure 1—figure supplement 2	pVNT (GMT; p value)	0–14 days; 2.05	52.66; <0.0001	40.14; <0.0001
		0–28 days; 2.0	146.71; <0.0001	104.93; <0.0001

*p Values were determined by performing one-way ANOVAs for repeated measures over Log₁₀ of data, followed by post hoc Bonferroni's multiple comparisons test. Red values indicate statistically significant results (p<0.05).